Related references
Note: Only part of the references are listed.Role for nuclear interleukin-37 in the suppression of innate immunity
Suzhao Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Association of IL-36 with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer
Aliyah M. Weinstein et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Cytokine-induced memory-like natural killer cells have enhanced function, proliferation, and in vivo expansion against ovarian cancer cells
Locke D. Uppendahl et al.
GYNECOLOGIC ONCOLOGY (2019)
Cell-Type-Specific Responses to Interleukin-1 Control Microbial Invasion and Tumor-Elicited Inflammation in Colorectal Cancer
Oxana Dmitrieva-Posocco et al.
IMMUNITY (2019)
Targeted codelivery of doxorubicin and IL-36γ expression plasmid for an optimal chemo-gene combination therapy against cancer lung metastasis
Yichao Chen et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2019)
Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation
Irena Kaplanov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Interleukin-1 receptor antagonist levels predict favorable outcome after bermekimab, a first-in-class true human interleukin-1 alpha antibody, in a phase III randomized study of advanced colorectal cancer
Razelle Kurzrock et al.
ONCOIMMUNOLOGY (2019)
IL-1 and IL-1 regulatory pathways in cancer progression and therapy
Alberto Mantovani et al.
IMMUNOLOGICAL REVIEWS (2018)
Biology of IL-38 and its role in disease
Frank L. van de Veerdonk et al.
IMMUNOLOGICAL REVIEWS (2018)
Regulation and function of interleukin-36 cytokines
Esen Yonca Bassoy et al.
IMMUNOLOGICAL REVIEWS (2018)
Suppression of inflammation and acquired immunity by IL-37
Giulio Cavalli et al.
IMMUNOLOGICAL REVIEWS (2018)
Intracellular mature IL-37 suppresses tumor metastasis via inhibiting Rac1 activation
Y. Li et al.
ONCOGENE (2018)
Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma Microenvironment
Kyohei Nakamura et al.
CANCER CELL (2018)
HER2 Overexpression Triggers an IL1α Proinflammatory Circuit to Drive Tumorigenesis and Promote Chemotherapy Resistance
Shou Liu et al.
CANCER RESEARCH (2018)
IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer
Te-Chia Wu et al.
CANCER RESEARCH (2018)
A novel stromal lncRNA signature reprograms fibroblasts to promote the growth of oral squamous cell carcinoma via LncRNA-CAF/interleukin-33
Liang Ding et al.
CARCINOGENESIS (2018)
The enigmatic role of IL-38 in inflammatory diseases
Thomas Garraud et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2018)
A tumor-myeloid cell axis, mediated via the cytokines IL-1α and TSLP, promotes the progression of breast cancer
Emma L. Kuan et al.
NATURE IMMUNOLOGY (2018)
nterleukin-33 enhanced the migration and invasiveness of human lung cancer cells
Zhiping Yang et al.
ONCOTARGETS AND THERAPY (2018)
Suppressing IL-36-driven inflammation using peptide pseudosubstrates for neutrophil proteases
Graeme P. Sullivan et al.
CELL DEATH & DISEASE (2018)
IL-37 inhibits invasion and metastasis in non-small cell lung cancer by suppressing the IL-6/STAT3 signaling pathway
Mingfang Jiang et al.
THORACIC CANCER (2018)
An Interleukin-1 Signature in Breast Cancer Treated with Interleukin-1 Receptor Blockade: Implications for Treating Cytokine Release Syndrome of Checkpoint Inhibitors
Charles Anthony Dinarello
CANCER RESEARCH (2018)
Interleukin-1 Beta-A Friend or Foe in Malignancies?
Rebekka Bent et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
The Role of IL-33/ST2 Pathway in Tumorigenesis
Kristen M. Larsen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
IL-33 facilitates proliferation of colorectal cancer dependent on COX2/PGE2
Yongkui Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
IL-1β inflammatory response driven by primary breast cancer prevents metastasis-initiating cell colonization
Zafira Castano et al.
NATURE CELL BIOLOGY (2018)
Regulatory Mechanisms of IL-33-ST2-Mediated Allergic Inflammation
Hiroaki Takatori et al.
FRONTIERS IN IMMUNOLOGY (2018)
Reduced interleukin-38 in non-small cell lung cancer is associated with tumour progression (Publication with Expression of Concern. See vol. 10, 2020)
Feng Wang et al.
OPEN BIOLOGY (2018)
Molecular mechanisms of IL-33-mediated stromal interactions in cancer metastasis
Patrik Andersson et al.
JCI INSIGHT (2018)
Elevated serum interleukin-37 level is a predictive biomarker of poor prognosis in epithelial ovarian cancer patients
Junwei Huo et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2017)
Exogenous IL-33 Restores Dendritic Cell Activation and Maturation in Established Cancer
Donye Dominguez et al.
JOURNAL OF IMMUNOLOGY (2017)
S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1β
Benjamin Weichand et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study
Tamas Hickish et al.
LANCET ONCOLOGY (2017)
Intracellular IL-37b interacts with Smad3 to suppress multiple signaling pathways and the metastatic phenotype of tumor cells
C. Luo et al.
ONCOGENE (2017)
Clinical implications of the novel cytokine IL-38 expressed in lung adenocarcinoma: Possible association with PD-L1 expression
Kazuki Takada et al.
PLOS ONE (2017)
Cancer cells induce interleukin-22 production from memory CD4(+) T cells via interleukin-1 to promote tumor growth
Cornelia Voigt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Wounds that heal and wounds that don't - The role of the IL-33/ST2 pathway in tissue repair and tumorigenesis
Neal L. Millar et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2017)
IL-36 suppresses proliferation of ovarian cancer cells
Lei Chang et al.
TUMOR BIOLOGY (2017)
Propiece IL-1α facilitates the growth of acute T-lymphocytic leukemia cells through the activation of NF-κB and SP1
Yinsheng Zhang et al.
ONCOTARGET (2017)
被撤回的出版物: Interleukin-37 mediates the antitumor activity in colon cancer through β-catenin suppression (Retracted article. See vol. 10, 2020)
Xiaofei Yan et al.
ONCOTARGET (2017)
The Role of IL-33-Dependent Inflammation in the Tumor Microenvironment
Marie-Helene Wasmer et al.
FRONTIERS IN IMMUNOLOGY (2017)
The Interleukin (IL)-1R1 pathway is a critical negative regulator of PyMT-mediated mammary tumorigenesis and pulmonary metastasis
Maryse Dagenais et al.
ONCOIMMUNOLOGY (2017)
IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils
Valeria Lucarini et al.
ONCOIMMUNOLOGY (2017)
Tbet and IL-36 cooperate in therapeutic DC-mediated promotion of ectopic lymphoid organogenesis in the tumor microenvironment
Aliyah M. Weinstein et al.
ONCOIMMUNOLOGY (2017)
IL-38 overexpression induces anti-inflammatory effects in mice arthritis models and in human macrophages in vitro
Marie-Astrid Boutet et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
An antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer
Charlotte O'Donnell et al.
BRITISH JOURNAL OF CANCER (2016)
Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways
Xiaoguang Tong et al.
MOLECULAR ONCOLOGY (2016)
Interleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells
Ole Audun Werner Haabeth et al.
ONCOIMMUNOLOGY (2016)
IL-33 signaling fuels outgrowth and metastasis of human lung cancer
Chunhong Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
IL-1β induces IL-6 production and increases invasiveness and estrogen-independent growth in a TG2-dependent manner in human breast cancer cells
Keunhee Oh et al.
BMC CANCER (2016)
Epidermal growth factor is a critical regulator of the cytokine IL-33 in intestinal epithelial cells
M. S. Islam et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis
Erin A. Marshall et al.
MOLECULAR CANCER (2016)
CCL22 and IL-37 inhibit the proliferation and epithelial-mesenchymal transition process of NSCLC A549 cells
Yu-Hua Chen et al.
ONCOLOGY REPORTS (2016)
Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
Rizwan Romee et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Interleukin-38 is released from apoptotic cells to limit inflammatory macrophage responses
Javier Mora et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2016)
Interleukin-33 enhances programmed oncosis of ST2L-positive low-metastatic cells in the tumour microenvironment of lung cancer
M. Akimoto et al.
CELL DEATH & DISEASE (2016)
Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironment
Miho Akimoto et al.
NATURE COMMUNICATIONS (2016)
IL-37 suppresses hepatocellular carcinoma growth by converting pSmad3 signaling from JNK/pSmad3L/c-Myc oncogenic signaling to pSmad3C/P21 tumor-suppressive signaling
Rui Liu et al.
ONCOTARGET (2016)
Exogenous IL-33 overcomes T cell tolerance in murine acute myeloid leukemia
Lei Qin et al.
ONCOTARGET (2016)
Interleukin-37 expression and its potential role in oral leukoplakia and oral squamous cell carcinoma
Lin Lin et al.
SCIENTIFIC REPORTS (2016)
Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention
Catherine Sautes-Fridman et al.
FRONTIERS IN IMMUNOLOGY (2016)
Discovery of a Metastatic Immune Escape Mechanism Initiated by the Loss of Expression of the Tumour Biomarker Interleukin-33
Iryna Saranchova et al.
SCIENTIFIC REPORTS (2016)
Targeting inflammasome/IL-1 pathways for cancer immunotherapy
Beichu Guo et al.
SCIENTIFIC REPORTS (2016)
IL-37 Is a Novel Proangiogenic Factor of Developmental and Pathological Angiogenesis
Tianshu Yang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Interleukin-18 enhances breast cancer cell migration via down-regulation of claudin-12 and induction of the p38 MAPK pathway
Yoolhee Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
IL-36γ Transforms the Tumor Microenvironment and Promotes Type 1 Lymphocyte-Mediated Antitumor Immune Responses
Xuefeng Wang et al.
CANCER CELL (2015)
The Association of Serum IL-33 and sST2 with Breast Cancer
Zhi-Ping Yang et al.
DISEASE MARKERS (2015)
Immunity, inflammation, and cancer: an eternal fight between good and evil
Shabnam Shalapour et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions
Cem Gabay et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
Circulating IL-33 level is associated with the progression of lung cancer
Myung Shin Kim et al.
LUNG CANCER (2015)
IL-37 mediates the antitumor activity in renal cell carcinoma
Yazhuo Jiang et al.
MEDICAL ONCOLOGY (2015)
IL-33 activates tumor stroma to promote intestinal polyposis
Rebecca L. Maywald et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8
Suzhao Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Expression of IL-1α correlates with distant metastasis in patients with head and neck squamous cell carcinoma
Xavier Leon et al.
ONCOTARGET (2015)
Interleukin 37 Expression Inhibits STAT3 to Suppress the Proliferation and Invasion of Human Cervical Cancer Cells
Sen Wang et al.
JOURNAL OF CANCER (2015)
Tumoral Expression of IL-33 Inhibits Tumor Growth and Modifies the Tumor Microenvironment through CD8+ T and NK Cells
Xin Gao et al.
JOURNAL OF IMMUNOLOGY (2015)
Context-dependent role of IL-18 in cancer biology and counter-regulation by IL-18BP
Marina Fabbi et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
Risk of Ovarian Cancer and the NF-κB Pathway: Genetic Association with IL1A and TNFSF10
Bridget Charbonneau et al.
CANCER RESEARCH (2014)
Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells
Ivan P. Jovanovic et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
IL-18 Enhances Immunosuppressive Responses by Promoting Differentiation into Monocytic Myeloid-Derived Suppressor Cells
Hui Xuan Lim et al.
JOURNAL OF IMMUNOLOGY (2014)
IL-18 Regulates Melanoma VLA-4 Integrin Activation through a Hierarchized Sequence of Inflammatory Factors
Maria Valcarcell et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study
David S. Hong et al.
LANCET ONCOLOGY (2014)
Examining IL-33 expression in the cervix of HPV-infected patients: a preliminary study comparing IL-33 levels in different stages of disease and analyzing its potential association with IFN-γ
Lei Wang et al.
MEDICAL ONCOLOGY (2014)
Tumor-Derived Interleukin-1 Promotes Lymphangiogenesis and Lymph Node Metastasis through M2-Type Macrophages
Kosuke Watari et al.
PLOS ONE (2014)
Interleukin-37 Mediates the Antitumor Activity in Hepatocellular Carcinoma: Role for CD57+NK Cells
Jing-Jing Zhao et al.
SCIENTIFIC REPORTS (2014)
Reduced IL-33 plasma levels in multiple myeloma patients are associated with more advanced stage of disease
Caterina Musolino et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Decreased expression of interleukin-36α correlates with poor prognosis in hepatocellular carcinoma
Qiu-Zhong Pan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Transgenic expression of IL-33 activates CD8+ T cells and NK cells and inhibits tumor growth and metastasis in mice
Kun Gao et al.
CANCER LETTERS (2013)
The Interleukin-1 Family: Back to the Future
Cecilia Garlanda et al.
IMMUNITY (2013)
The Role of IL-1β in the Early Tumor Cell-Induced Angiogenic Response
Yaron Carmi et al.
JOURNAL OF IMMUNOLOGY (2013)
A Dose-Escalation Study of Recombinant Human Interleukin-18 in Combination With Rituximab in Patients With Non-Hodgkin Lymphoma
Michael J. Robertson et al.
JOURNAL OF IMMUNOTHERAPY (2013)
The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma
Su-Feng Chen et al.
JOURNAL OF PATHOLOGY (2013)
A Role for Interleukin-1 Alpha in the 1,25 Dihydroxyvitamin D3 Response in Mammary Epithelial Cells
Sophia L. Maund et al.
PLOS ONE (2013)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
Cancer-Induced Immunosuppression: IL-18-Elicited Immunoablative NK Cells
Magali Terme et al.
CANCER RESEARCH (2012)
Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors
Jing Ni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
IL-1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activation
Yijing Li et al.
MOLECULAR CANCER (2012)
Gene expression profiling identifies sST2 as an effector of ErbB2-driven breast carcinoma cell motility, associated with metastasis
J. Gillibert-Duplantier et al.
ONCOGENE (2012)
IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist
Frank L. van de Veerdonk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Trial watch Prognostic and predictive value of the immune infiltrate in cancer
Laura Senovilla et al.
ONCOIMMUNOLOGY (2012)
Interleukin-1α Mediates the Antiproliferative Effects of 1,25-Dihydroxyvitamin D3 in Prostate Progenitor/Stem Cells
Sophia L. Maund et al.
CANCER RESEARCH (2011)
IL-18 Induces PD-1-Dependent Immunosuppression in Cancer
Magali Terme et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma
Ivan Jovanovic et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18Rα
I-K Choi et al.
GENE THERAPY (2011)
Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer
Ole Audun Werner Haabeth et al.
NATURE COMMUNICATIONS (2011)
Interleukin 1α Sustains the Expression of Inflammatory Factors in Human Pancreatic Cancer Microenvironment by Targeting Cancer-Associated Fibroblasts
Vegard Tjomsland et al.
NEOPLASIA (2011)
IL-37: a new anti-inflammatory cytokine of the IL-1 family
Diana Boraschi et al.
EUROPEAN CYTOKINE NETWORK (2011)
The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer
Irving C. Allen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Cancer Cell-Derived IL-1α Promotes HGF Secretion by Stromal Cells and Enhances Metastatic Potential in Pancreatic Cancer Cells
Donghui Xu et al.
JOURNAL OF SURGICAL ONCOLOGY (2010)
IL-37 is a fundamental inhibitor of innate immunity
Marcel F. Nold et al.
NATURE IMMUNOLOGY (2010)
Interleukin-1 (IL-1) Pathway
Axel Weber et al.
SCIENCE SIGNALING (2010)
A Phase 2, Randomized Study of SB-485232, rhIL-18, in Patients With Previously Untreated Metastatic Melanoma
Ahmad A. Tarhini et al.
CANCER (2009)
Interleukin-18 increases metastasis and immune escape of stomach cancer via the downregulation of CD70 and maintenance of CD44
Jae Seung Kang et al.
CARCINOGENESIS (2009)
Expression of ADAM33 Is a Novel Regulatory Mechanism in IL-18-Secreted Process in Gastric Cancer
Kyung-Eun Kim et al.
JOURNAL OF IMMUNOLOGY (2009)
Host-Derived Interleukin-1α Is Important in Determining the Immunogenicity of 3-Methylcholantrene Tumor Cells
Moshe Elkabets et al.
JOURNAL OF IMMUNOLOGY (2009)
IL-18 Paradox in Pancreatic Carcinoma: Elevated Serum Levels of Free IL-18 are Correlated With Poor Survival
Anna Carbone et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Secreted Interleukin-1α Induces a Metastatic Phenotype in Pancreatic Cancer by Sustaining a Constitutive Activation of Nuclear Factor-κB
Davide Melisi et al.
MOLECULAR CANCER RESEARCH (2009)
Induction of a Chronic Disease State in Patients With Smoldering or Indolent Multiple Myeloma by Targeting Interleukin 1β-Induced Interleukin 6 Production and the Myeloma Proliferative Component
John A. Lust et al.
MAYO CLINIC PROCEEDINGS (2009)
IL-18-producing Salmonella inhibit tumor growth
M. Loeffler et al.
CANCER GENE THERAPY (2008)
Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation
Hiroko Hayakawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Role of serum interleukin-18 as a prognostic factor in patients with hepatocellular carcinoma
Pisit Tangkijvanich et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Interleukin-18 is a critical factor for vascular endothelial growth factor-enhanced migration in human gastric cancer cell lines
K-E Kim et al.
ONCOGENE (2007)
Interleukin-1β-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors
Yakov Krelin et al.
CANCER RESEARCH (2007)
The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1β
Ksenya Shchors et al.
GENES & DEVELOPMENT (2006)
Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions
RN Apte et al.
EUROPEAN JOURNAL OF CANCER (2006)
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
J Schmitz et al.
IMMUNITY (2005)
Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1β-induced neovascularization and tumor growth
S Nakao et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Innate immunity mediated by the cytokine IL-1 homologue 4 (IL-1H4/IL-1F7) induces IL-12-dependent adaptive and profound antitumor immunity
WT Gao et al.
JOURNAL OF IMMUNOLOGY (2003)
Proinflammatory cytokine IL-1β promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors:: In vivo analysis of tumor-stromal interaction
Y Saijo et al.
JOURNAL OF IMMUNOLOGY (2002)
Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer
FR Villegas et al.
LUNG CANCER (2002)
Identification of a novel human cytokine gene in the interleukin gene cluster on chromosome 2q12-14
JT Bensen et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2001)
Cloning and characterization of IL-1HY2, a novel interleukin-1 family member
HS Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population
K Imai et al.
LANCET (2000)
Share Paper
